Fibrosis Archives - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria.

Gene editing kills female mosquitoes that spread malaria

HQ Team July 10, 2023: US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria..

by HealthQuill
July 10, 2023
0 Comments

Medical Pharma

Mediar bags $105 mn from big pharmas to pursue fibrosis treatments

Mediar Therapeutics gets $105 million financing from Novartis, Pfizer, Eli Lilly and Bristol Myers to advance portfolio of first-in-class fibrosis therapies.

by HealthQuill
March 16, 2023
2 Comments

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new entity focusing on treating cancers and fibrosis.

Drugs Pharma

Redx, Jounce to merge in a $425 million all-share deal

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.

by HealthQuill
February 24, 2023
0 Comments